Oxford BioMedica plc acquires GMP manufacturing facility.

Oxford BioMedica plc has announced that it has agreed to acquire a manufacturing facility based in Oxford, UK, from RecipharmCobra Biologics, the specialist biologics division of Recipharm AB, for a purchase price of GBP 1.9 M. The acquisition and operation of this manufacturing facility is a planned use of proceeds following the company's recent GBP 20 M fundraising which closed on 10 Jan 2011. The acquisition of the facility is expected to complete by the end of Feb 2011. The manufacturing facility will enable Oxford BioMedica to have greater control of the production of its proprietary LentiVector gene delivery technology in order to support five of the company's clinical programmes. …